DK183882A - Fremgangsmaade til fremstilling af phen(alk)oxy-substituerede oxirancarboxylsyrer - Google Patents

Fremgangsmaade til fremstilling af phen(alk)oxy-substituerede oxirancarboxylsyrer Download PDF

Info

Publication number
DK183882A
DK183882A DK183882A DK183882A DK183882A DK 183882 A DK183882 A DK 183882A DK 183882 A DK183882 A DK 183882A DK 183882 A DK183882 A DK 183882A DK 183882 A DK183882 A DK 183882A
Authority
DK
Denmark
Prior art keywords
denotes
phen
alk
oxy
integer
Prior art date
Application number
DK183882A
Other languages
English (en)
Other versions
DK171890B1 (da
Inventor
Klaus Eistetter
Gerhard Ludwig
Horst Wolf
Erich Rapp
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of DK183882A publication Critical patent/DK183882A/da
Application granted granted Critical
Publication of DK171890B1 publication Critical patent/DK171890B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

Figure DK183882AD00021
og eventuelt påfølgende hydrolyse, saltdannelse eller omesterificering.
Forbindelserne I har hypoglycæmisk virkning på varmblodede dyr, herunder mennesker.
DK183882A 1980-08-25 1982-04-23 Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden DK171890B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH639780 1980-08-25
CH639780 1980-08-25
CH152681 1981-03-06
CH152681 1981-03-06
PCT/EP1981/000136 WO1982000643A1 (en) 1980-08-25 1981-08-24 Substituted oxiranecarbonic acids,preparation and pharmaceutical utilisation thereof
EP8100136 1981-08-24

Publications (2)

Publication Number Publication Date
DK183882A true DK183882A (da) 1982-04-23
DK171890B1 DK171890B1 (da) 1997-08-04

Family

ID=25687902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183882A DK171890B1 (da) 1980-08-25 1982-04-23 Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden

Country Status (16)

Country Link
US (1) US4337267A (da)
EP (1) EP0046590B1 (da)
JP (1) JPS6059914B2 (da)
AU (1) AU549447B2 (da)
CA (1) CA1167050A (da)
DE (1) DE3170608D1 (da)
DK (1) DK171890B1 (da)
ES (1) ES504922A0 (da)
GR (1) GR75741B (da)
IE (1) IE51534B1 (da)
IL (1) IL63627A (da)
NZ (1) NZ198136A (da)
PH (1) PH21847A (da)
PT (1) PT73563B (da)
WO (1) WO1982000643A1 (da)
YU (1) YU206681A (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000751A2 (en) * 1985-08-02 1987-02-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of oxirancarboxylic acids for the treatment of hyperlipemia
GB2202222B (en) * 1987-03-16 1991-03-27 American Home Prod Fluorooxirane carboxylates
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US6013666A (en) * 1996-07-02 2000-01-11 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
US5932763A (en) * 1997-05-15 1999-08-03 Bayer Corporation Inhibition of matrix metalloproteases by 2-(ω-arolalkyl)-4-biaryl-4-oxobutyric acids
DE10115938A1 (de) 2001-03-30 2002-10-10 Medigene Ag Ges Fuer Molekular Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon
WO2003026582A2 (en) * 2001-09-26 2003-04-03 Emisphere Technologies Inc. Method of preparing phenoxy alkanoic, alkenoic, and alkynoic acids and salts thereof via a dicarboxylate intermediate
AU2004212004B2 (en) * 2003-02-13 2008-01-10 Albert Einstein College Of Medicine Of Yeshiva University Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
WO2006088798A2 (en) * 2005-02-14 2006-08-24 Albert Einstein College Of Medicine Of Yeshiva University Modulation of hypothalamic atp-sensitive potassium channels
WO2009156479A1 (en) 2008-06-27 2009-12-30 Meta-Iq Aps Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
KR102722949B1 (ko) 2015-06-15 2024-10-28 엔엠디 파마 에이/에스 신경근 장애의 치료에 사용하기 위한 화합물
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US12440477B2 (en) 2017-12-14 2025-10-14 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551078A (en) * 1975-09-22 1979-08-22 Mcneilab Inc Alkyl-substituted glycidates and thioglycidates
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
DE3063144D1 (en) * 1979-09-07 1983-06-16 Byk Gulden Lomberg Chem Fab Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them

Also Published As

Publication number Publication date
DE3170608D1 (en) 1985-06-27
AU549447B2 (en) 1986-01-30
IL63627A0 (en) 1981-11-30
JPS57501233A (da) 1982-07-15
DK171890B1 (da) 1997-08-04
PH21847A (en) 1988-03-17
PT73563B (en) 1983-07-14
AU7447581A (en) 1982-03-04
YU206681A (en) 1983-10-31
ES8300730A1 (es) 1982-11-16
CA1167050A (en) 1984-05-08
US4337267A (en) 1982-06-29
EP0046590B1 (de) 1985-05-22
EP0046590A2 (de) 1982-03-03
IE51534B1 (en) 1987-01-07
WO1982000643A1 (en) 1982-03-04
PT73563A (en) 1981-09-01
ES504922A0 (es) 1982-11-16
JPS6059914B2 (ja) 1985-12-27
GR75741B (da) 1984-08-02
IE811931L (en) 1982-02-25
EP0046590A3 (en) 1982-04-07
NZ198136A (en) 1983-12-16
IL63627A (en) 1984-11-30

Similar Documents

Publication Publication Date Title
DK457879A (da) Fremgangsmaade til fremstilling af 3,5-dihydroxypentanonsyreesterderivater
KR850003393A (ko) 1-벤질-아미노알킬-피롤리디논의 제조방법
DE3761307D1 (de) Herstellung von fibraten.
IE811931L (en) Oxiranes.
ES470878A1 (es) Procedimiento para la aclaracion optica de materiales orga- nicos
KR840000508A (ko) 4-아닐리노피리미딘 유도체의 제조방법
JPS5570841A (en) Forming method of dye image
PT71773A (de) Verfahren zur herstellung von substituierten oxirancarbonsauren
ES503989A0 (es) Procedimiento para la obtencion de un producto de poliadi- cion-policondensacion que lleva grupos de nitrogeno basico
KR830008987A (ko) 니트로아닐린의 제조방법
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
ATE2324T1 (de) Triazolyl-alken-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
KR890012991A (ko) 광학활성을 갖는 4-옥소-1-벤조피란-2-카르복시산 유도체 및 중간체의 제법
DK552682A (da) Fremgangsmaade til fremstilling af hydroxybenzylaminobenzener
KR840005434A (ko) 잡초류 억제용 신화합물
HUP9800869A1 (hu) Eljárás klór-ketoaminok előállítására karbamátok alkalmazásával
KR850003407A (ko) 유기인산 에스테르 유도체의 제조방법
DK179991A (da) Fremgangsmaade til fremstilling af 7-amino-3-chlor-3-cephem-4-carboxylsyreestere
RU95118432A (ru) Способ получения замещенных или незамещенных 1,4-дигидро-4-оксо-2- или 3-хинолинкарбоновых кислот
KR840008647A (ko) 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법
JPS54121126A (en) Dye image formation process for silver halide photographic material
ATE40117T1 (de) O-substituierte 3-oxypyridiniumsalze, verfahren zu ihrer herstellung und ihre verwendung als fungizide fuer den pflanzenschutz.
KR830005255A (ko) N-포스포노메틸글리시노니트릴 디아릴 에스테르의 퍼플루오로아미드의 제조방법
KR870006014A (ko) 피리미딜멀캅토-아실아닐리드의 제조방법
KR830003487A (ko) 벤조디아제핀 유도체의 제조방법

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
ARF Application refused